Explore 3 Stock Ideas & Industry Insights Download Free Report

Ayujoy Herbals Ltd

Consumer Defensive US AJOY

0.0022USD
0.00(0%)

Last update at 2026-06-18T13:30:00Z

Day Range

0.00220.0022
LowHigh

52 Week Range

0.00220.01
LowHigh

Fundamentals

  • Previous Close 0.0022
  • Market Cap0.14M
  • Volume0
  • P/E Ratio0.02
  • Dividend Yield-%
  • EBITDA8.19M
  • Revenue TTM70.87M
  • Revenue Per Share TTM1.50
  • Gross Profit TTM 23.88M
  • Diluted EPS TTM0.10

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-12-31 2022-12-31 2021-12-31 2017-12-31 2016-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2017-12-31 2016-12-31
Income before tax -0.13639M -0.66727M -0.42523M 7.66M 4.44M
Minority interest - - - - -
Net income -0.13639M -0.66727M -0.42523M 6.39M 3.27M
Selling general administrative - - - - -
Selling and marketing expenses - - - - -
Gross profit - 0.16M - 18.99M 18.26M
Reconciled depreciation - - - - -
Ebit -0.30428M -0.66727M -0.66179M 7.66M 4.44M
Ebitda -0.13639M -0.66591M -0.42523M 8.07M 5.02M
Depreciation and amortization 0.17M 0.00136M 0.24M 0.41M 0.58M
Non operating income net other - - - - -
Operating income -0.06514M -0.66727M -0.42523M 7.66M 7.22M
Other operating expenses 0.07M 0.86M 0.43M 48.31M 48.64M
Interest expense - - - - -
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.16789M 0.00000M -0.23656M 1.27M 1.17M
Total revenue - 0.19M - 55.97M 55.87M
Total operating expenses 0.07M 0.83M 0.43M 11.33M 11.04M
Cost of revenue - 0.02M - 36.98M 37.60M
Total other income expense net -0.07125M -0.00000M 0.00000M 0.00000M -2.78050M
Discontinued operations - - - - -
Net income from continuing ops - - - - -
Net income applicable to common shares - - - - -
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2017-12-31 2016-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2017-12-31 2016-12-31
Total assets 0.00289M - 1.60M 42.98M 36.59M
Intangible assets - - 1.50M - -
Earning assets - - - - -
Other current assets - - - 13.87M 11.74M
Total liab 0.06M - 0.93M 0.06M 0.06M
Total stockholder equity -0.06188M - 0.67M 42.93M 36.53M
Deferred long term liab - - - - -
Other current liab 0.06M - - 0.00160M 0.00149M
Common stock 0.62M - 0.60M 0.47M 0.47M
Capital stock - - - - -
Retained earnings -1.39648M - -0.59146M 40.57M 34.18M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 0.00289M - 0.08M 0.41M 0.40M
Cash and equivalents - - - - -
Total current liabilities 0.06M - 0.00051M 0.06M 0.06M
Current deferred revenue - - - 0.05M 0.05M
Net debt -0.00289M - 0.85M -0.41385M -0.40083M
Short term debt - - - - 0.00000M
Short long term debt - - - - -
Short long term debt total - - 0.93M - -
Other stockholder equity 0.71M - 0.66M 1.89M 1.89M
Property plant equipment - - - - -
Total current assets 0.00289M - 0.10M 32.44M 26.19M
Long term investments - - - - -
Net tangible assets - - - - -
Short term investments - - - 17.04M 13.02M
Net receivables - - - 1.08M 1.01M
Long term debt - - - - -
Inventory - - 0.02M 0.03M 0.03M
Accounts payable 0.00046M - 0.00051M 0.00419M 0.00392M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - 9.90M 9.66M
Deferred long term asset charges - - - - -
Non current assets total - - 1.50M 10.54M 10.40M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2017-12-31 2016-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2017-12-31 2016-12-31
Investments - - - - -
Change to liabilities - - - - -
Total cashflows from investing activities - - - - -1.53022M
Net borrowings - - - - -
Total cash from financing activities 0.00431M -0.92869M 0.72M - -
Change to operating activities - - - - -
Net income -0.13639M -0.66727M -0.42523M 6.39M 3.27M
Change in cash 0.00271M -0.07501M -0.33867M 0.01M 0.02M
Begin period cash flow 0.00018M 0.08M 0.41M 0.40M 0.38M
End period cash flow 0.00289M 0.00018M 0.08M 0.41M 0.40M
Total cash from operating activities -0.00159M -0.64484M -0.44840M 6.72M 1.54M
Issuance of capital stock - - - - -
Depreciation - 0.00136M - 0.41M 0.58M
Other cashflows from investing activities - - - - -0.24671M
Dividends paid - - - - -
Change to inventory 0.00008M 0.02M -0.02302M -0.00036M 0.00006M
Change to account receivables - - - -0.07306M -0.01907M
Sale purchase of stock - - - - -
Other cashflows from financing activities 0.00431M -0.92869M 0.72M -6.71122M -
Change to netincome - - - - -
Capital expenditures 0.00000M 0.00000M 0.28M 0.55M 0.14M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.06M 0.02M -0.02317M -0.07631M -0.02003M
Stock based compensation - - - - -
Other non cash items 0.07M -0.02107M 0.02M 0.89M -1.11741M
Free cash flow -0.00159M -0.64484M -0.73033M 6.18M 1.40M

Peer Comparison

Sector: Consumer Defensive Industry: Packaged Foods

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
AJOY
Ayujoy Herbals Ltd
- -% 0.0022 0.02 - 0.0019 -
NSRGF
Nestle SA
- -% 98.98 26.86 18.76 3.13 7.10 3.81 21.70
NSRGY
Nestle SA ADR
-0.78 0.80% 97.32 26.82 18.66 3.18 7.07 3.81 21.70
GPDNF
Danone S.A
- -% 74.80 25.33 17.39 1.97 2.55 1.88 11.70
DANOY
Danone PK
0.22 1.46% 15.29 24.23 17.64 1.88 2.57 1.88 11.70

Reports Covered

Stock Research & News

Profile

Ayujoy Herbals Ltd., a research and testing organization, provides technical and regulatory consulting for biotechnical products, pharmaceuticals, diagnostics, medical equipment, and devices. The company serves various pharmaceutical companies in India and Southeast Asia to get FDA approval and facilitate exports of pharmaceuticals, and medical products and devices to the United States. Its services include analytical QC, QA functions, readiness for inspections, compliance, validation, clinical trial management, regulatory/legal, preparation of regulatory filings, compliance assessments, risk assessments, mock FDA audits, medical device support, CMC support, GMP training, facility layout consulting, and training, as well as utilities, process, IT, computer, and cleaning validation services. The company was incorporated in 2008 and is based in Mumbai, India.

Ayujoy Herbals Ltd

10/234 Dadisheth Agiary Lane, Mumbai, India, 400002

Key Executives

Name Title Year Born
Ms. Dipika Purohit Chairman, Chief Exec. Officer and Pres NA
Ms. Dipika Purohit Chairman, Chief Executive Officer and President NA
Mr. William Murray Senior Vice President of International Sales & Marketing NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.